Neil Majithia

818 total citations
19 papers, 565 citations indexed

About

Neil Majithia is a scholar working on Oncology, Neurology and Genetics. According to data from OpenAlex, Neil Majithia has authored 19 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 4 papers in Neurology and 4 papers in Genetics. Recurrent topics in Neil Majithia's work include Cancer Treatment and Pharmacology (6 papers), Botulinum Toxin and Related Neurological Disorders (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Neil Majithia is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Botulinum Toxin and Related Neurological Disorders (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Neil Majithia collaborates with scholars based in United States, Australia and Canada. Neil Majithia's co-authors include Charles L. Loprinzi, Thomas J. Smith, Andreas S. Beutler, Kathryn J. Ruddy, Sarah M. Temkin, Dawn L. Hershman, Brian Allen, John Kidd, Nanda Singh and Gloria M. Petersen and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Leukemia.

In The Last Decade

Neil Majithia

19 papers receiving 555 citations

Peers

Neil Majithia

ONCOL

HEMAT

PHYSI

Yuichi Konuma Japan

Carine Chaleteix France

Robert Chew United States

Veronika Lang Germany

Manuel Martín‐González Spain

Enikő Sáfrány Hungary

Emma Searle United Kingdom

Rai‐Hua Lai Taiwan

Johnique T. Atkins United States

Sandra M. J. Paulissen Netherlands

Yuichi Konuma Japan

Neil Majithia

142 ×0.4

ONCOL

184 ×1.2

176 ×1.2

HEMAT

38 ×0.5

PHYSI

27 ×0.3

Citations per year, relative to Neil Majithia Neil Majithia (= 1×) peers Yuichi Konuma

Countries citing papers authored by Neil Majithia

Since Specialization

Citations

This map shows the geographic impact of Neil Majithia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Majithia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Majithia more than expected).

Fields of papers citing papers by Neil Majithia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Majithia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Majithia. The network helps show where Neil Majithia may publish in the future.

Co-authorship network of co-authors of Neil Majithia

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Majithia. A scholar is included among the top collaborators of Neil Majithia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Majithia. Neil Majithia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Hazim, Antonious, Neil Majithia, Stephen J. Murphy, et al.. (2021). Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas. Cancer Immunology Immunotherapy. 70(9). 2651–2656. 3 indexed citations

Yadav, Siddhartha, et al.. (2020). Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab. JCO Oncology Practice. 16(7). e573–e580. 34 indexed citations

Loprinzi, Charles L., Jennifer Le‐Rademacher, Neil Majithia, et al.. (2019). Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial. Supportive Care in Cancer. 28(3). 1183–1197. 45 indexed citations

Majithia, Neil, Marie Christine Aubry, Stephen J. Murphy, & Aaron S. Mansfield. (2019). Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas. International Journal of Radiation Oncology*Biology*Physics. 104(1). 237–238. 1 indexed citations

Loprinzi, Charles L., Jennifer Le‐Rademacher, Neil Majithia, et al.. (2018). Scrambler therapy for established chemotherapy-induced neuropathy: A randomized phase II trial.. Journal of Clinical Oncology. 36(15_suppl). 10016–10016. 1 indexed citations

Chaffee, Kari G., Ann L. Oberg, Robert R. McWilliams, et al.. (2017). Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Genetics in Medicine. 20(1). 119–127. 97 indexed citations

Majithia, Neil, Patrick E. MacDonald, Jocelyn E. Manning Fox, et al.. (2017). STEAP4 expression in human islets is associated with differences in body mass index, sex, HbA1c, and inflammation. Endocrine. 56(3). 528–537. 6 indexed citations

Majithia, Neil, Yiyi Yan, Lisa A. Kottschade, et al.. (2017). The prognostic role of preoperative serum lactate dehydrogenase (LDH) in patients with resected advanced melanoma.. Journal of Clinical Oncology. 35(15_suppl). e21054–e21054. 3 indexed citations

Majithia, Neil, S. Vincent Rajkumar, M. Q. Lacy, et al.. (2016). Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents. Leukemia. 30(11). 2208–2213. 75 indexed citations

10.

Majithia, Neil, Thomas J. Smith, Patrick J. Coyne, et al.. (2016). Scrambler Therapy for the management of chronic pain. Supportive Care in Cancer. 24(6). 2807–2814. 51 indexed citations

11.

Leon‐Ferre, Roberto A., Neil Majithia, & Charles L. Loprinzi. (2016). Management of hot flashes in women with breast cancer receiving ovarian function suppression. Cancer Treatment Reviews. 52. 82–90. 26 indexed citations

12.

Petersen, Gloria M., Kari G. Chaffee, Robert R. McWilliams, et al.. (2016). Genetic heterogeneity and survival among pancreatic adenocarcinoma (PDAC) patients with positive family history.. Journal of Clinical Oncology. 34(15_suppl). 4108–4108. 9 indexed citations

13.

Majithia, Neil, Charles L. Loprinzi, & Thomas J. Smith. (2016). New Practical Approaches to Chemotherapy-Induced Neuropathic Pain: Prevention, Assessment, and Treatment.. PubMed. 30(11). 1020–9. 59 indexed citations

14.

Majithia, Neil, Sarah M. Temkin, Kathryn J. Ruddy, et al.. (2015). National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons. Supportive Care in Cancer. 24(3). 1439–1447. 78 indexed citations

15.

Majithia, Neil, S. Vincent Rajkumar, Martha Q. Lacy, et al.. (2015). Outcomes of primary refractory multiple myeloma and the impact of novel therapies. American Journal of Hematology. 90(11). 981–985. 29 indexed citations

16.

Majithia, Neil, Philip J. Atherton, Jacqueline M. Lafky, et al.. (2015). Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up. Supportive Care in Cancer. 24(3). 1219–1226. 11 indexed citations

17.

Majithia, Neil & Axel Grothey. (2015). Regorafenib in the treatment of colorectal cancer. Expert Opinion on Pharmacotherapy. 17(1). 137–145. 16 indexed citations

18.

Sim, Austin J., Neil Majithia, Edward B. Stelow, et al.. (2014). Patterns of Distant Failure and Second Primary Cancers in Patients with Oropharyngeal Squamous Cell Carcinoma: Implications for Surveillance Methodology. 3(3). 3 indexed citations

19.

Sim, Austin J., Edward B. Stelow, Neil Majithia, et al.. (2014). Prognostic Significance of p16 and Its Relationship With Human Papillomavirus in Pharyngeal Squamous Cell Carcinomas. JAMA Otolaryngology–Head & Neck Surgery. 140(7). 647–647. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact